Al-Dossari Dalal Salem, Al-Zaagi Ibrahim Abdulaziz, Bamogaddam Reem Faisal, Alnajrani Rashid Hamoud, Alnajrani Nouf Rashid, Alajami Hamdan Najib, AlOtaibi Raghad Abdullah, AlShammary Khulood Salim, AlOtaibi Anfal Jamal, Yousaf Anum, Ali Sheraz
Pharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.
College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.
Pharm Pract (Granada). 2022 Jul-Sep;20(3):2709. doi: 10.18549/PharmPract.2022.3.2709. Epub 2022 Sep 1.
This study investigates the hospital pharmacists' awareness of important facts about the COVID-19 disease and their source of information, as well as their perception.
This cross-sectional study using a self-administered questionnaire was conducted from November 2020 to March 2021 in the Kingdom of Saudi Arabia (KSA). The questionnaire was developed via electronic platform and invitations were sent to pharmacists working in private and government hospitals. A multivariate logistic regression was used to identify factors associated with awareness of COVID-19.
A total of 272 pharmacists submitted their responses via weblink. Many pharmacists (n=228, 84%) followed the latest COVID-19 updates on treatment and updated their information mainly through World Health Organization documents (n=151, 56%). Pharmacists working in secondary and tertiary hospitals were relatively five-times times (AOR = 4.59; 95% CI: 1.69-12.8; p-value = 0.003) and three-times (AOR = 2.93; 95% CI: 1.35-6.72; p-value = 0.008) more aware of COVID-19 than those working in primary hospitals. Pharmacists with prior adequate knowledge regarding epidemics and pandemics were two-times more likely to have a good awareness of COVID-19 compared to those who had received none (AOR = 2.15; 95% CI: 1.09-4.35; p-value = 0.030).
Half of the pharmacists believed that they received required education in the past about epidemics and pandemics, and many follow the recent COVID-19 updates on medicines predominantly from the WHO followed by the government awareness campaigns. Many pharmacists believed they have a key role in the management of epidemics/pandemics via their hospital pharmacy. However, this study identified certain awareness gaps regarding COVID-19, highlighting areas of improvement.
本研究调查医院药剂师对2019冠状病毒病重要事实的认知、其信息来源以及他们的看法。
2020年11月至2021年3月在沙特阿拉伯王国进行了这项采用自填式问卷的横断面研究。问卷通过电子平台制定，并向在私立和公立医院工作的药剂师发出邀请。采用多因素逻辑回归来确定与2019冠状病毒病认知相关的因素。
共有272名药剂师通过网络链接提交了回复。许多药剂师（n = 228，84%）关注了2019冠状病毒病治疗的最新进展，并且主要通过世界卫生组织的文件（n = 151，56%）来更新他们的信息。在二级和三级医院工作的药剂师对2019冠状病毒病的认知程度分别是在一级医院工作的药剂师的约五倍（比值比 = 4.59；95%置信区间：1.69 - 12.8；p值 = 0.003）和三倍（比值比 = 2.93；95%置信区间：1.35 - 6.72；p值 = 0.008）。与没有接受过任何关于流行病和大流行病相关知识培训的药剂师相比，之前具备足够的流行病和大流行病相关知识的药剂师对2019冠状病毒病有良好认知的可能性高出两倍（比值比 = 2.15；95%置信区间：1.09 - 4.35；p值 = 0.030）。
一半的药剂师认为他们过去接受了关于流行病和大流行病的必要教育，并且许多人主要通过世界卫生组织的信息，其次是政府的宣传活动来关注近期2019冠状病毒病在药物方面的进展。许多药剂师认为他们通过医院药房在流行病/大流行病的管理中发挥着关键作用。然而，本研究发现了在2019冠状病毒病认知方面的某些差距，突出了需要改进的领域。
